This PDF is the current document as it appeared on Public Inspection on 01/24/2014 at 08:45 am.
Department of the Army, DoD.
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/640,832, entitled “Benzonapthyridine Composition and Uses,” filed on April 13, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
The invention relates to compositions comprising benzonapthridine small molecule immune potentiators (SMIPs) that are capable of stimulating or Modulating an immune response in a subject that has had pre- or post- exposure to a pathogen such as hemorrhagic fever virus.Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01436 Filed 1-24-14; 8:45 am]
BILLING CODE 3710-08-P